HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
U Bacher Selected Research
U Bacher Research Topics
Disease
5
Multiple Myeloma
03/2013 - 06/2008
3
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016 - 04/2011
3
Philadelphia Chromosome
03/2014 - 03/2005
3
Neoplasms (Cancer)
09/2013 - 08/2008
2
Lymphoma (Lymphomas)
02/2015 - 01/2014
2
Chromosome Aberrations (Chromosome Abnormalities)
07/2014 - 03/2010
2
Residual Neoplasm
03/2014 - 08/2008
1
Primary Myelofibrosis (Myelosclerosis)
11/2017
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2016
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2014
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2014
1
BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
09/2013
1
Peripheral Nervous System Diseases (PNS Diseases)
03/2013
1
Fatigue
03/2013
1
Neutropenia
03/2013
1
Thrombocytopenia (Thrombopenia)
03/2013
1
Pathologic Complete Response
10/2012
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2012
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2011
1
Mannose-Binding Protein Deficiency
01/2010
1
Infections
01/2010
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2008
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2005
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2004
Drug/Important Bio-Agent (IBA)
3
Lenalidomide (CC 5013)
FDA Link
01/2016 - 02/2010
2
Imatinib Mesylate (Gleevec)
FDA Link
03/2014 - 03/2005
2
Tyrosine Kinase Inhibitors
IBA
03/2014 - 03/2010
1
Thrombopoietin Receptors
IBA
11/2017
1
Calreticulin
IBA
11/2017
1
S 0139 (97-139)
IBA
07/2014
1
DNA (Deoxyribonucleic Acid)
IBA
02/2014
1
Carrier Proteins (Binding Protein)
IBA
09/2013
1
Rituximab (Mabthera)
FDA Link
10/2012
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
08/2012
1
Nucleophosmin
IBA
04/2011
1
HLA-DR Antigens (HLA-DR)
IBA
02/2010
1
Mannose-Binding Lectin (Mannan-Binding Lectin)
IBA
01/2010
1
fludarabine
IBA
06/2008
1
Melphalan (Alkeran)
FDA Link
Generic
06/2008
1
Interferon-alpha (Interferon Alfa)
IBA
03/2005
1
Genetic Markers (Genetic Marker)
IBA
06/2004
Therapy/Procedure
3
Stem Cell Transplantation
11/2017 - 08/2008
3
Transplantation
02/2015 - 08/2008
2
Homologous Transplantation
11/2017 - 03/2014
2
Cell Transplantation
03/2014 - 01/2014
2
Hematopoietic Stem Cell Transplantation
10/2011 - 06/2008
1
Autologous Transplantation
01/2016
1
Therapeutics
03/2013
1
Drug Therapy (Chemotherapy)
10/2012
1
Salvage Therapy
02/2010